Since our ACRP ACRP-CP exam review materials are accurate and valid our service is also very good. We are 7*24 online service. When you want to ask any questions or share with us your ACRP-CP passing score you will reply you in 3 hours. We have one-year service warranty that we will send you the latest ACRP-CP exam review materials if you want or other service. If you pass ACRP-CP with a good mark and want to purchase other ACRP exams review materials we will give you discount. Or if you stands for your company and want to long-term cooperate with us we welcome and give you 50%+ discount from the second year.
Our IT system department staff checks the updates every day. Once the ACRP-CP exam review materials are updated we will notice our customers ASAP. We make sure that all ACRP-CP exam review materials we sell out are accurate, ACRP-CP valid and latest. As for the payment we advise people using the Credit Card which is a widely used in international online payments and the safer, faster way to send money, receive money or set up a merchant account for both buyers and sellers. If you have any query about the payment we are pleased to solve for you. (ACRP-CP pass review - ACRP Certified Professional Exam)
We assure you 100% pass for sure. If you fail the ACRP-CP exam you can send us your unqualified score we will full refund to you or you can choose to change other subject exam too. We aim to "Customer First, Service Foremost", that's why we can become the PassReview in this area.
Instant Download ACRP-CP Exam Braindumps: Upon successful payment, Our systems will automatically send the product you have purchased to your mailbox by email. (If not received within 12 hours, please contact us. Note: don't forget to check your spam.)
ACRP ACRP-CP Exam Syllabus Topics:
| Section | Weight | Objectives |
|---|---|---|
| Topic 1: Professionalism and Ethical Practice | 15% | - Professional standards
|
| Topic 2: Ethical and Participant Safety Considerations | 19% | - Safety monitoring and reporting
|
| Topic 3: Study Design and Conduct | 17% | - Study implementation
|
| Topic 4: Data Management and Informatics | 17% | - Data reporting
|
| Topic 5: Clinical Study Operations | 15% | - Site management
|
| Topic 6: Regulatory and Compliance Requirements | 17% | - International standards
|
ACRP Certified Professional Sample Questions:
1. Which of the following statements is TRUE about an EDC system?
A) IRB/IEC approval is required before the use of the computerized system.
B) There should be an audit trail to track data entries, deletions, and changes.
C) The eCRF should be an exact page-by-page replica of the paper CRF.
D) A separate workstation should be made available for the monitor.
2. The investigator/institution should permit:
A) Monitoring and auditing by the appropriate regulatory authority(ies), and inspection by the sponsor.
B) Monitoring and inspection by the appropriate regulatory authority(ies), and auditing by the sponsor.
C) Monitoring and inspection by the sponsor, and auditing by the appropriate regulatory authority(ies).
D) Monitoring and auditing by the sponsor, and inspection by the appropriate regulatory authority(ies).
3. When assessing the monitoring needs for a study, sponsors should:
A) Ensure monitoring visits are conducted at periodic intervals with a minimum of monthly monitoring visits.
B) Ensure monitors have the scientific and/or clinical knowledge needed to monitor the trial adequately.
C) Permit PIs to select a monitor for their site as long as they are independent of the PI.
D) Use central monitoring instead of conducting physical monitoring visits at sites.
4. In order to conduct open-label, parallel group clinical trials according to sound scientific principles, which of the following design elements should be included?
A) Privacy controls
B) Blinding
C) Placebo-controlled
D) Randomization
5. Preliminary evidence suggests a low-dose anti-cancer drug given for a short period of time may reduce the risk of developing cancer in patients who are at increased risk for developing cancer. The drug has potentially serious side effects. What is the MOST important question to consider before designing a clinical trial to test this hypothesis?
A) How effective is the drug at treating patients that have been previously diagnosed with cancer?
B) How likely are patients at high risk of cancer going to develop cancer during the study?
C) How does the risk of developing cancer compare to the anticipated side effects from the drug?
D) How willing are current patients to participate in a trial with potentially serious side effects?
Solutions:
| Question # 1 Answer: B | Question # 2 Answer: B | Question # 3 Answer: B | Question # 4 Answer: D | Question # 5 Answer: C |






